Remove 10
Remove 2020 Remove Document Remove Healthcare Remove Risk
article thumbnail

Regulatory Update: NAIC Summer 2020 National Meeting

Data Matters

The National Association of Insurance Commissioners (NAIC) held its Summer 2020 National Meeting (Summer Meeting) from July 27 to August 14, 2020. Annuity Suitability Working Group Drafting FAQ Document to Facilitate Uniformity in State Adoption of Revised Suitability in Annuity Transactions Model Regulation.

article thumbnail

Regulatory Update: NAIC Summer 2021 National Meeting

Data Matters

Highlights include, among others, adoption of revised risk-based capital bond factors for life insurers, amendments to SSAP No. NAIC Adopts Revised Risk-Based Capital Bond Factors for Life Insurers. NAIC Adopts FAQ Document to Facilitate Uniformity in State Adoption of Revised Suitability in Annuity Transactions Model Regulation .

Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

article thumbnail

The benefits of AI in healthcare

IBM Big Data Hub

Artificial intelligence is used in healthcare for everything from answering patient questions to assisting with surgeries and developing new pharmaceuticals, benefitting both patients and healthcare systems. AI computer-assisted documentation can provide clinicians with suggestions that keep medical records as thorough as possible.

article thumbnail

Regulatory Update: NAIC Fall 2020 National Meeting

Data Matters

The National Association of Insurance Commissioners (NAIC) held its Fall 2020 National Meeting (Fall Meeting) December 3-9, 2020. The International Insurance Relations (G) Committee will be scheduling a conference call in early 2021 to discuss the NAIC’s comments to the IAIS’ draft document ahead of the January 22 comment deadline.

article thumbnail

Regulatory Update: NAIC Summer 2018 National Meeting

Data Matters

While it has been determined that the GCC will utilize a risk-based capital (RBC) aggregation approach in order to leverage existing legal capital requirements, it is not clear which entities within any group will be subject to the GCC or how the GCC will apply to those entities within a group that do not have existing capital requirements.

article thumbnail

EDPB’s Position on Clinical Trials Creates Friction with Other EU Legislation

HL Chronicle of Data Protection

A basic legal requirement that pharmaceutical and medical device companies conducting clinical trials must always respect when conducting a clinical trial is the obligation to obtain patients’ consent to their participation for clinical trials. The consent must be in writing.

GDPR 40